Solutions 4 Wealth, LTD Galectin Therapeutics Inc Transaction History
Solutions 4 Wealth, LTD
- $56.7 Billion
- Q1 2025
A detailed history of Solutions 4 Wealth, LTD transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Solutions 4 Wealth, LTD holds 36,003 shares of GALT stock, worth $86,047. This represents 0.08% of its overall portfolio holdings.
Number of Shares
36,003
Previous 36,003
-0.0%
Holding current value
$86,047
Previous $46.4 Million
5.43%
% of portfolio
0.08%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding GALT
# of Institutions
103Shares Held
10.1MCall Options Held
587KPut Options Held
2.02M-
Vanguard Group Inc Valley Forge, PA2.19MShares$5.24 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$3.74 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.22MShares$2.92 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA853KShares$2.04 Million0.0% of portfolio
-
Geneos Wealth Management Inc.423KShares$1.01 Million0.02% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $142M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...